| Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer (NCT05257408) | Corcept Therapeutics | 2022-06-29 |
| Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer (NCT05059782) | Xi'an Jiaotong University | 2021-10-10 |
| Impact of Specific Monitoring of Intraoperative Analgesia Under General Anesthesia on Chronic Pain After Ovarian Cancer Surgery (NCT04906187) | Institut Bergonié | 2021-05-31 |
| Feasibility Study of a 4 Stage Bowel Obstruction Cancer Diet (NCT04898842) | Royal Surrey County Hospital NHS Foundation Trust | 2021-03-02 |
| Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies (NCT04561362) | BicycleTx Limited | 2020-07-17 |
| Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival (NCT04402333) | Royal Surrey County Hospital NHS Foundation Trust | 2020-06-26 |
| Supportive Programs for Supporting Optimal Recovery in Participants Undergoing Gynecological Surgery (NCT03681405) | Wake Forest University Health Sciences | 2018-12-07 |
| Study to Evaluate the Safety and Efficacy of TSR-042, Bevacizumab, and Niraparib in Participants With Recurrent Ovarian Cancer (NCT05751629) | Tesaro, Inc. | 2018-11-15 |
| Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer (NCT03562897) | Catalysis SL | 2018-10-25 |
| COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. (NCT03667716) | Compugen Ltd | 2018-09-06 |
| EHealth Mindful Movement and Breathing in Improving Outcomes in Participants Undergoing Gynecologic Surgery (NCT03379376) | Wake Forest University Health Sciences | 2018-04-05 |
| Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types (NCT03012620) | UNICANCER | 2017-07-05 |
| Fluid Balance During Surgery for Ovarian Cancer (NCT03006939) | University Hospital, Bonn | 2016-12-01 |
| HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life (NCT03000192) | University Hospital Southampton NHS Foundation Trust | 2016-08-01 |
| Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel (NCT01821833) | New Mexico Cancer Research Alliance | 2016-05-24 |
| Trabectedin/Caelyx vs Cisplatin Hypersensitivity in Relapsed Ovarian Cancer Patients Allergic to Platinum (NCT05512676) | Oslo University Hospital | 2016-03-07 |
| Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host (NCT02732860) | University Health Network, Toronto | 2015-12-01 |
| Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer (NCT02520115) | Barbara Ann Karmanos Cancer Institute | 2015-08-01 |
| Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02470585) | AbbVie | 2015-07-14 |
| Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer (NCT01896778) | Roswell Park Cancer Institute | 2013-10-04 |
| [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer (NCT01608009) | Imperial College London | 2012-07-01 |
| Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors (NCT01929720) | Ohio State University Comprehensive Cancer Center | 2011-08-01 |
| Family Communication of Hereditary Breast and Ovarian Cancer Risk Among African Americans (NCT01374685) | National Human Genome Research Institute (NHGRI) | 2011-06-07 |
| Prediction of Ovarian Malignancy in the Presence of Sonographic Pelvic Mass (NCT01477788) | HaEmek Medical Center, Israel | 2011-05-01 |
| Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer (NCT01139957) | Gynecologic Oncology Group | 2010-06-07 |
| Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer (NCT00494442) | AstraZeneca | 2007-06-11 |
| Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer (NCT00436215) | National Cancer Institute (NCI) | 2006-12-12 |
| DOXIL for Consolidation Therapy in Ovarian Cancer. (NCT00248248) | Southeastern Gynecologic Oncology | 2005-10-01 |
| Phase II CT-2103/Carboplatin in Ovarian Cancer (NCT00069901) | CTI BioPharma | 2003-02-01 |
| Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 (NCT00034281) | Takeda | 2002-06-01 |
| A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse) (NCT00001938) | National Cancer Institute (NCI) | 2000-04-24 |
| p53 Vaccine for Ovarian Cancer (NCT00001827) | National Cancer Institute (NCI) | 1999-07-26 |
| Microarray Analysis for Human Genetic Disease (NCT00001898) | National Human Genome Research Institute (NHGRI) | 1999-06-29 |